BrightSpring Health Services, Inc. (BTSG)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$60.73-1.14%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
Intact: The reason to own it still holds.
BrightSpring Health Services grows revenue about 16% yearly, backed by raised guidance to nearly $15B in 2026. Profit margins improve with operating income rising from $50.7M to $121.4M in one year. The company benefits from specialty pharmacy growth and tuck-in deals. Share buybacks show management confidence.
Revenue growth could slow if tuck-in deals or specialty pharmacy expansion falter. Operating income gains may stall if cost controls weaken. High valuation multiples limit upside if growth disappoints.
The price reflects about 16% revenue growth and sits roughly 26% above our fair value near $56. Our fair value is below the Street median, indicating some caution. We see the market fairly pricing solid growth but with limited margin for error.
Breaks if: Gross profit falls below $338M quarterly
Breaks if: Operating income falls below $50M quarterly
Breaks if: Revenue falls below $12.5B in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
BTSG represents a durable compounder with a focus on consistent revenue growth and profitability. The current thesis state is intact, supported by recent earnings beats and management's commitment to growth priorities.
The market appears to price in a stretched valuation compared to peers, reflecting a premium of 1.8. There is a 15% expectations gap, indicating that investors have high hopes for future performance.
Management is on track to meet its growth targets, with strong revenue and adjusted EBITDA growth reported. However, there is a low probability of missing expectations, though recent industry trends could pose risks.
The thesis hinges on maintaining revenue growth and profitability while navigating potential downturns in the healthcare sector. Key factors include the performance of sector bellwethers and any changes in guidance from BTSG.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats impacting the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Over the next 1 to 3 years, BTSG's performance will depend on its ability to sustain growth amidst sector challenges. Not investment advice.